View Older Stories View More Recent Stories
-
Hims & Hers Health, Inc. (HIMS) call put ratio 1.1 calls to 1 put
-
Hims House podcast shares statement from Hims & Hers regarding Bloomberg report
-
After-hours movers: UnitedHealth, Applied Materials, Intel, Hims & Hers Health
-
Hims & Hers Health, Inc. (HIMS) Probed By US FTC Over Cancellation Practices - Bloomberg
-
Hims & Hers Health, Inc. (HIMS) call put ratio 1.6 calls to 1 put with a focus on August 55 calls
-
HIMS Shares Decline Amid Lower Revenue Per Order For GLP-1 Following Novo Nordisk Collaboration Termination, Securities Class Action Pending -- Hagens Berman
-
Popular stocks volume: HIMS INTC SNAP OPEN UNH SMCI RIVN HOOD COIN UBER MSTR PFE
-
Novo Nordisk files 14 new lawsuits over compounded semaglutide drugs
-
Hims & Hers Health, Inc. (HIMS) on Watch; Novo Nordisk (NVO) Expands Legal Action to Protect US Patients From Non-FDA-approved Compounded 'Semaglutide'
-
Popular stocks volume: HIMS HOOD PFE SMCI SOFI COIN
-
BTIG Reiterates Buy Rating on Hims and Hers (HIMS), PT $85
-
BofA Securities Reiterates Underperform Rating on Hims and Hers (HIMS), PT $28
-
Truist on Hims and Hers (HIMS): 'Revs Below As Core Growth Continues to Soften'
-
Hims and Hers (HIMS) PT Raised to $48 at TD Cowen
-
Hims and Hers (HIMS) PT Raised to $43 at Leerink Partners
-
After-hours movers: Palantir, Hims & Hers, Vertex Pharma and more
-
Hims & Hers Health (HIMS) Tops Q2 EPS by 2c, Revenue Misses, Offers Guidance
-
Hims & Hers Health, Inc. (HIMS) call put ratio 1 call to 1.4 puts into quarter results
-
Hims & Hers Health, Inc. (HIMS) call put ratio 1 call to 1.6 puts into quarter results
-
Hims & Hers Health, Inc. (HIMS) Faces Securities Class Actions After Novo Nordisk Cancels Partnership Over "Deceptive" Marketing of Wegovy(R) - Hagens Berman
-
Hims & Hers reports weight loss data for compounded GLP-1 treatments
-
Hims & Hers Health, Inc. (HIMS) options active on 310K contracts
-
Hims & Hers (HIMS) reportedly makes statement on congressional letter to FDA
-
Hims & Hers Health, Inc. (HIMS) Alleged "Deceptive" Marketing of Wegovy(R) Triggers Securities Class Actions - HIMS Investors with Losses Encouraged to Contact Hagens Berman
-
Hims & Hers Health, Inc. (NYSE: HIMS) Falls, Group Of 81 Bipartisan Lawmakers Sign Letter On Glp-1 Action
-
Popular stocks with increasing volume: HIMS MSTR RKT AAL PLTR NIO HOOD COIN LCID SOFI MRNA
-
HIMS CLASS ACTION ALERT: Kessler Topaz Meltzer & Check, LLP Reminds Hims & Hers Health, Inc. Shareholders of Securities Fraud Class Action Lawsuit
-
ROSEN, LEADING INVESTOR COUNSEL, Encourages Hims & Hers Health, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - HIMS
-
SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Hims & Hers Health
-
HIMS INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Hims & Hers Health, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
-
HIMS CLASS NOTICE: BFA Law Reminds Hims & Hers Health, Inc. Investors of the Pending Securities Fraud Class Action and August 25 Court Deadline
-
Hims & Hers Health, Inc. (HIMS) Alleged "Deceptive" Marketing of Wegovy(R) Triggers Securities Class Actions - HIMS Investors with Losses Encouraged to Contact Hagens Berman
-
Kessler Topaz Meltzer & Check, LLP Announces Securities Fraud Class Action Lawsuit Filed Against Hims & Hers Health, Inc.
-
ROSEN, NATIONAL TRIAL LAWYERS, Encourages Hims & Hers Health, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - HIMS
-
INVESTOR ALERT: Berger Montague Advises Hims & Hers Health (HIMS) Investors to Inquire About a Securities Fraud Class Action by August 25, 2025
-
HIMS DEADLINE REMINDER: Hims & Hers Health, Inc. Investors with Losses are Reminded to Contact BFA Law by the Upcoming August 25 Securities Fraud Deadline
-
HIMS ANNOUNCEMENT: Kessler Topaz Meltzer & Check, LLP Notifies Investors of a Class Action Lawsuit Against Hims & Hers Health, Inc. (HIMS)
-
ROSEN, NATIONAL INVESTOR COUNSEL, Encourages Hims & Hers Health, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - HIMS
-
HIMS Equity Alert: Kessler Topaz Meltzer & Check, LLP Alerts Shareholders of Securities Fraud Class Action Lawsuit Filed against Hims & Hers Health, Inc. (HIMS)
-
HIMS SECURITIES NOTICE: Investors of Hims & Hers Health, Inc. are Alerted to Contact BFA Law before August 25 Class Action Deadline
-
HIMS INVESTOR DEADLINE: Hims & Hers Health, Inc. Investors with Substantial Losses Have Opportunity to Lead Investor Class Action Lawsuit
-
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Hims & Hers Health, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - HIMS
-
CLASS ACTION NOTICE FOR HIMS: Kessler Topaz Meltzer & Check, LLP Reminds Hims & Hers Health, Inc. Shareholders of Securities Fraud Class Action Lawsuit and Encourages Investors with Losses to Contact
-
HIMS INVESTORS: Kirby McInerney LLP Reminds Hims & Hers Health, Inc. Investors of Important Deadline and Encourages Investors to Contact the Firm
-
HIMS & HERS HEALTH INC. CLASS ACTION NOTICE: Berger Montague Encourages Investors With Substantial Losses to Contact the Firm By August 25, 2025
-
Hims & Hers Health, Inc. (HIMS) Alleged "Deceptive" Marketing of Wegovy(R) Triggers Securities Class Actions - HIMS Investors with Losses Encouraged to Contact Hagens Berman
-
HIMS Investors Have the Opportunity to Lead the Hims & Hers Health Securities Fraud Lawsuit with Faruqi & Faruqi, LLP
-
BofA Securities Continues Dislike of Hims and Hers (HIMS), 'Catalyst path: Litigation, guidance, and new products/geos'
-
ROSEN, SKILLED INVESTOR COUNSEL, Encourages Hims & Hers Health, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - HIMS
-
HIMS STOCK LOSSES: Hims & Hers Health, Inc. Shareholders that Suffered Losses are Notified to Contact BFA Law before the Expiration of the August 25 Legal Deadline
